Afatinib Suspended Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02470065Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.